Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced that it has received Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a patent entitled “Modification and Compositions of Human Secretoglobin Proteins” (United States Patent Application No. 13/843,773).

Read more…